Vaxcyte, Inc.
NASDAQ:PCVX · NASDAQ Global Select
+$1.94 today
Vol 2.26M · Avg 1.44M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+54.71%
Period High
$63.04
Period Low
$29.67
Latest
$51.44
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Arrowhead Pharmaceuticals, Inc.
NASDAQ:ARWR
$11.68B
Krystal Biotech, Inc.
NASDAQ:KRYS
$10.35B
TG Therapeutics, Inc.
NASDAQ:TGTX
$8.01B
Alkermes plc
NASDAQ:ALKS
$7.52B
Metsera, Inc.
MTSR
$7.43B
Arcellx, Inc.
ACLX
$6.73B
PTC Therapeutics, Inc.
NASDAQ:PTCT
$6.54B
CRISPR Therapeutics AG
NASDAQ:CRSP
$5.31B
Akero Therapeutics, Inc.
AKRO
$4.50B
Crinetics Pharmaceuticals, Inc.
NASDAQ:CRNX
$3.84B
What is the latest PCVX filing?
The latest filing shown is 4 dated Jun 16, 2026.
How many recent filings does PCVX have?
Intrinsic Alpha currently shows 20 recent filings for PCVX.
Explore More
Continue the stock analysis
Jump to another research area for this company.